C4PAIN ApS: Financial statements 2020
CVR: 32292402
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 658,252 and a net result of DKK 541,607 compared with DKK 399,804 the year before. That is an increase of 38.9% compared with the year before. Equity in the 2020 report amounted to DKK 2,499,969. The solvency ratio was 90.6%.
- Gross Profit
- DKK 658,252
- Profit/Loss
- DKK 541,607
- Equity
- DKK 2,499,969
- Total Assets
- DKK 2,760,289
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 658 t. | 542 t. | 2.5 mio. | - |
| 2019 | - | 474 t. | 400 t. | 2 mio. | - |
| 2018 | - | 1.8 mio. | 1.4 mio. | 1.6 mio. | - |
| 2017 | - | 666 t. | 660 t. | 812 t. | - |
| 2016 | - | -453 t. | -374 t. | 152 t. | - |
Official annual report
How creditworthy is C4PAIN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
C4PAIN ApS has published its annual report for 2019. Gross profit came to DKK 474,060, and the net result was DKK 399,804.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.